Pictet Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$648K Buy
+540
New +$552K 0.69% 31
2019
Q1
Sell
-7,300
Closed -$845K 73
2018
Q4
$845K Sell
7,300
-15,900
-69% -$1.78M 0.34% 52
2018
Q3
$2.49M Hold
23,200
0.78% 29
2018
Q2
$1.98M Buy
23,200
+200
+0.9% +$16.4K 0.68% 34
2018
Q1
$1.78M Hold
23,000
0.63% 37
2017
Q4
$1.94M Sell
23,000
-3,000
-12% -$255K 0.57% 37
2017
Q3
$2.22M Sell
26,000
-800
-3% -$65.6K 0.66% 33
2017
Q2
$2.21M Buy
26,800
+23,200
+644% +$1.89M 0.7% 27
2017
Q1
$303K Hold
3,600
0.09% 68
2016
Q4
$265K Buy
+3,600
New +$268K 0.09% 74

Other funds holding LLY

Pictet Bank & Trust's LLY Position: Q2 2026 in Review

Pictet Bank & Trust opened a new position in Eli Lilly (LLY) in Q2 2026: 540 shares worth $648K. The stake represents 0.69% of the portfolio and ranks #31 among its holdings. This is a return to the name: Pictet Bank & Trust previously reported a position in LLY as recently as Q4 2018.

Pictet Bank & Trust first reported a position in LLY in Q4 2016 and has held it in 10 quarters since. The position peaked at $2.49M in Q3 2018. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pictet Bank & Trust held 540 shares of Eli Lilly worth $648K as of Q2 2026.
  • Eli Lilly was a new Pictet Bank & Trust position in Q2 2026.
  • Eli Lilly made up 0.69% of Pictet Bank & Trust's portfolio in Q2 2026, its #31 holding.
  • Pictet Bank & Trust first reported a position in Eli Lilly in Q4 2016 and has held it in 10 quarters since.
  • Pictet Bank & Trust's Eli Lilly position peaked at $2.49M in Q3 2018.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pictet Bank & Trust's 13F filing for Q2 2026, filed 24 Jul 2026.